Upregulated OCT3 has the potential to improve the survival of colorectal cancer patients treated with (m)FOLFOX6 adjuvant chemotherapy

ConclusionsHigh OCT3 expression in CRC tissues may be a protective factor for CRC patients treated with (m)FOLFOX6.
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research